Tag: #healthcare71 results
A new study led by UCSF indicates that breast cancer incidence among Asian American women is rising, particularly in younger demographics and aggressive subtypes, challenging previous health assumptions.
This article explores the clinical presentation and risks of corpus luteum rupture, a gynecological emergency often misdiagnosed as other abdominal conditions. It emphasizes the importance of accurate diagnostic procedures for timely intervention.
A comprehensive global study led by UBC confirms that mRNA vaccine technology is both highly effective and safe. The research synthesized data from clinical trials and real-world monitoring to validate the long-term performance of this technology.
The tumor genetic testing industry faces scrutiny over irregular charging and 'large panel' technical obsessions that often lack clinical cost-effectiveness. Experts suggest shifting NGS capabilities toward drug R&D rather than excessive clinical screening.
Zhenjian and Ruichu are competing for market share in county-level hospitals. The strategy focuses on surgical volume to drive long-term consumable replenishment.
The rise of county-level medical consortia (医共体) is centralizing drug procurement and patient flow, creating significant pressure on traditional retail pharmacies while highlighting new opportunities in specialized 'dual-channel' drug services.
Moderna has been granted $50 million to accelerate the development of an mRNA-based vaccine targeting the Bundibugyo strain of Ebola. This initiative aims to address urgent public health needs during active outbreaks.
The medical condition previously known as Polycystic Ovary Syndrome (PCOS) has been renamed to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its systemic nature. This change aims to reduce stigma and improve clinical understanding of its metabolic and endocrine impacts.
A study of 2,000 UK residents reveals that 15% now use AI chatbots for medical advice instead of visiting a GP. One in four of these users cited long NHS waiting lists as the primary reason for turning to AI.
At GReAT 2026 summit, Fourier signed strategic pacts with Singapore's NHG Health and Nagoya University for rehab robotics. Demos combined BCI with exoskeletons for intent-driven gait training and GR-2 for remote vital signs via facial scanning. Focus on scaling clinical apps and 'brain-body intelligent rehab port'.